1. Home
  2. CMPS vs MCI Comparison

CMPS vs MCI Comparison

Compare CMPS & MCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPS
  • MCI
  • Stock Information
  • Founded
  • CMPS 2020
  • MCI 1971
  • Country
  • CMPS United Kingdom
  • MCI United States
  • Employees
  • CMPS 166
  • MCI N/A
  • Industry
  • CMPS Biotechnology: Pharmaceutical Preparations
  • MCI Trusts Except Educational Religious and Charitable
  • Sector
  • CMPS Health Care
  • MCI Finance
  • Exchange
  • CMPS Nasdaq
  • MCI Nasdaq
  • Market Cap
  • CMPS 502.7M
  • MCI 419.4M
  • IPO Year
  • CMPS 2020
  • MCI N/A
  • Fundamental
  • Price
  • CMPS $5.20
  • MCI $22.76
  • Analyst Decision
  • CMPS Strong Buy
  • MCI
  • Analyst Count
  • CMPS 7
  • MCI 0
  • Target Price
  • CMPS $17.00
  • MCI N/A
  • AVG Volume (30 Days)
  • CMPS 1.8M
  • MCI 40.4K
  • Earning Date
  • CMPS 10-30-2025
  • MCI 01-01-0001
  • Dividend Yield
  • CMPS N/A
  • MCI 8.46%
  • EPS Growth
  • CMPS N/A
  • MCI N/A
  • EPS
  • CMPS N/A
  • MCI 1.82
  • Revenue
  • CMPS N/A
  • MCI N/A
  • Revenue This Year
  • CMPS N/A
  • MCI N/A
  • Revenue Next Year
  • CMPS N/A
  • MCI N/A
  • P/E Ratio
  • CMPS N/A
  • MCI $9.88
  • Revenue Growth
  • CMPS N/A
  • MCI N/A
  • 52 Week Low
  • CMPS $2.25
  • MCI $12.96
  • 52 Week High
  • CMPS $7.53
  • MCI $19.24
  • Technical
  • Relative Strength Index (RSI)
  • CMPS 63.09
  • MCI 73.55
  • Support Level
  • CMPS $5.01
  • MCI $21.02
  • Resistance Level
  • CMPS $5.33
  • MCI $21.90
  • Average True Range (ATR)
  • CMPS 0.32
  • MCI 0.46
  • MACD
  • CMPS 0.04
  • MCI 0.10
  • Stochastic Oscillator
  • CMPS 81.63
  • MCI 95.08

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

About MCI Barings Corporate Investors

Barings Corporate Investors is a closed-end management investment company. Its investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. The Trust's principal investments are privately placed, below-investment grade, long-term debt obligations, including bank loans and mezzanine debt instruments. The Trust typically purchases these investments, which are not publicly tradable, directly from their issuers in private placement transactions, and the investments are typically made to small or middle market companies.

Share on Social Networks: